Performing multiple biomarker tests delays initiation of amyloid-targeting treatments.

Saved in:
Bibliographic Details
Title: Performing multiple biomarker tests delays initiation of amyloid-targeting treatments.
Authors: Hofmann A; Department of Neurology Washington University School of Medicine St. Louis Missouri USA.; Knight Alzheimer Disease Research Center Washington University School of Medicine St. Louis Missouri USA., Paczynski M; Department of Neurology Washington University School of Medicine St. Louis Missouri USA.; Knight Alzheimer Disease Research Center Washington University School of Medicine St. Louis Missouri USA., Ponisio MR; Mallinckrodt Institute of Radiology Washington University School of Medicine St. Louis Missouri USA., Saef B; Department of Neurology Washington University School of Medicine St. Louis Missouri USA., Roberts JP; Department of Neurology Washington University School of Medicine St. Louis Missouri USA., Powell WJB; Institute for Informatics Data Science & Biostatistics Washington University School of Medicine St. Louis Missouri USA., Gupta A; Institute for Informatics Data Science & Biostatistics Washington University School of Medicine St. Louis Missouri USA., Oh I; Institute for Informatics Data Science & Biostatistics Washington University School of Medicine St. Louis Missouri USA., Hofford M; Institute for Informatics Data Science & Biostatistics Washington University School of Medicine St. Louis Missouri USA., Posey Z; Department of Neurology Washington University School of Medicine St. Louis Missouri USA., Aldinger M; Department of Neurology Washington University School of Medicine St. Louis Missouri USA., Benzinger TLS; Mallinckrodt Institute of Radiology Washington University School of Medicine St. Louis Missouri USA., Morris JC; Department of Neurology Washington University School of Medicine St. Louis Missouri USA.; Knight Alzheimer Disease Research Center Washington University School of Medicine St. Louis Missouri USA., Snider BJ; Department of Neurology Washington University School of Medicine St. Louis Missouri USA.; Knight Alzheimer Disease Research Center Washington University School of Medicine St. Louis Missouri USA., Schindler SE; Department of Neurology Washington University School of Medicine St. Louis Missouri USA.; Knight Alzheimer Disease Research Center Washington University School of Medicine St. Louis Missouri USA.
Source: Alzheimer's & dementia (Amsterdam, Netherlands) [Alzheimers Dement (Amst)] 2026 Jun 29; Vol. 18 (3), pp. e70387. Date of Electronic Publication: 2026 Jun 29 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Wiley on behalf of the Alzheimer's Association Country of Publication: United States NLM ID: 101654604 Publication Model: eCollection Cited Medium: Print ISSN: 2352-8729 (Print) Linking ISSN: 23528729 NLM ISO Abbreviation: Alzheimers Dement (Amst) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2352-8729
DOI:10.1002/dad2.70387